| NCT Number | NCT07283822 |
| Lead Sponsor | Seda S. Tolu
Collaborators: Incyte Corporation |
| Conditions | Non-Hodgkin Lymphoma, Hodgkin Disease Lymphoma, Non-Hodgkin Lymphoma Refractory/ Relapsed, Hodgkin Disease Recurrent, Gray Zone Lymphoma, Peripheral T-cell Lymphoma, Cutaneous T-Cell Lymphomas, Primary Mediastinal B Cell Lymphoma |
| Enrollment | 53 participants |
| Start Date | 2025-12-03 |
| Primary Completion | 2028-01 (estimated) |
| Study Completion | 2029-01 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-16 |